Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, April 20, 2025
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Facebook
Twitter
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
Home
Pharma News
CDM
Clinical Research
Medical Writing
Regulatory Affairs
More
Clinical coding (Medical)
Clinical Research Associate
Centralized Monitoring
HEOR (Health Economics and Outcome Research)
Pharmacovigilanc​e
Scientific Writing
Other
About us
Search
Home
Latest Pharma-News
Latest Pharma-News
Latest Pharma-News
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
admin
-
April 11, 2025
Latest Pharma-News
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
admin
-
April 9, 2025
Latest Pharma-News
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
admin
-
April 9, 2025
Latest Pharma-News
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
admin
-
April 9, 2025
Latest Pharma-News
FDA Alerts Patients of Potential to Miss Critical Safety Alerts Due to Phone Settings When Using Smartphone-Compatible Diabetes Devices
admin
-
February 10, 2025
Latest Pharma-News
U.S. FDA granted fast track designation for Nanobiotix for the investigation of first-in-class nbtxr3 in head and neck cancer
admin
-
February 13, 2020
0
Latest Pharma-News
Astex Pharmaceuticals announces U.S. Food and Drug Administration (FDA) acceptance for the review of NDA for the combination oral hypomethylating agent cedazuridine and decitabine...
admin
-
February 13, 2020
0
Latest Pharma-News
U.S. FDA Acceptance of New Drug Application for FibroGen’s Roxadustat for the Treatment of Anemia of Chronic Kidney Disease
admin
-
February 12, 2020
0
Latest Pharma-News
Fennec Pharmaceuticals Completes Rolling Submission of NDA to U.S. Food and Drug Administration for PEDMARK™ and Also Submits Marketing Authorization Application (MAA) to the...
admin
-
February 12, 2020
0
Latest Pharma-News
Roche provides topline results from the investigator-led Phase II/III trial with gantenerumab in exceptionally inherited form of Alzheimer’s disease
admin
-
February 12, 2020
0
Latest Pharma-News
The Scottish Medicines Consortium approves first two ‘ultra-orphan’ pathway meds
admin
-
February 12, 2020
0
Latest Pharma-News
Zealand Pharma announces proposal to acquire Valeritas
admin
-
February 10, 2020
0
Latest Pharma-News
Extended coronavirus outbreak in China may affect the Indian pharmaceutical industry
admin
-
February 10, 2020
0
Latest Pharma-News
Clariant Masterbatches introduces brilliant new metallic aesthetic; targets premium packaging
admin
-
February 10, 2020
0
Latest Pharma-News
Bionj awarded Amarin with innovator award for vascepa® development and regulatory approval cardiovascular risk
admin
-
February 9, 2020
0
Latest Pharma-News
Nestlé Health Sciences and valbiotis agree to create and market TOTUM-63, a plant-derived active substance with clinically proven metabolic health benefits
admin
-
February 9, 2020
0
Latest Pharma-News
USFDA Authorizes Marketing of the First Cardiac Ultrasound Software That Uses Artificial Intelligence to Guide User
admin
-
February 8, 2020
0
1
...
129
130
131
...
145
Page 130 of 145
- Advertisment -
Most Read
J&J announced Icotrokinra results show 75% of adolescents with plaque psoriasis achieved completely clear skin
April 11, 2025
Sanofi’s Tolebrutinib phase 3 data published in NEJM demonstrate benefit on disability progression in multiple sclerosis
April 9, 2025
Novartis receives FDA accelerated approval for Vanrafia for proteinuria reduction in primary IgA nephropathy
April 9, 2025
AstraZeneca showcases innovation in infectious disease protection at ESCMID Global 2025
April 9, 2025